Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Inovio Pharmaceuticals, Inc.    INO

INOVIO PHARMACEUTICALS, INC.

(INO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 3733813303 073--
Entreprise Value (EV)1 3733813303 0733 0733 073
P/E ratio -3,82x-3,81x-2,73x-27,8x15,2x-70,1x
Yield ------
Capitalization / Revenue 8,83x12,5x80,3x227x6,33x34,1x
EV / Revenue 8,83x12,5x80,3x227x6,33x34,1x
EV / EBITDA ------
Price to Book ------
Nbr of stocks (in thousands) 90 29695 347100 010158 096--
Reference price (USD) 4,134,003,3019,419,419,4
Last update 03/14/201803/12/201903/12/2020---
1
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 42,230,54,1113,648590,3
EBITDA ------
Operating profit (EBIT)1 -83,6-94,1-111-1016,47-33,5
Operating Margin -198%-309%-2 702%-743%1,33%-37,1%
Pre-Tax Profit (EBT)1 -88,2-94,8-121-1110,18-41,3
Net income1 -88,2-97,0-119-1110,18-44,1
Net margin -209%-318%-2 903%-818%0,04%-48,9%
EPS2 -1,08-1,05-1,21-0,701,28-0,28
Dividend per Share ------
Last update 03/14/201803/12/201903/12/2020---
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow1 ----52,01 401957
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex1 10,32,09-7,6228,619,6
Capex / Sales 24,4%6,84%-56,2%5,89%21,7%
Last update 03/14/201803/12/201903/12/202007/30/202007/30/202007/01/2020
1 USD in Million
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (USD)
3 073 395 007
Net sales (USD)
4 111 930
Number of employees
190
Sales / Employee (USD)
21 642
Free-Float
97,5%
Free-Float capitalization (USD)
2 997 176 658
Avg. Exchange 20 sessions (USD)
718 493 492
Average Daily Capital Traded
23,4%
EPS & Dividend